It is a pharma private limited company based in Vishakhapatnam, Andhra Pradesh, India, established in 2020.
2020 | Vishakhapatnam, Andhra Pradesh, India | ActiveQule Pharma Private Limited, a active private limited company, was established on 16 November 2020 in Vishakhapatnam, Andhra Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304AP2020PTC116442. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Employing 22 professional, Its leadership includes Nityananda Reddy Kambam (Director), Santhanam Subramanian (Director), Rama Krishna (Director). Past directors included Sanjeev Indravadan Dani, Nityananda Reddy Kambam, Phaneemdra Prasad Gorla. It holds ₹545.00 Cr open charges and no settled loans. Its latest AGM occurred on 01 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit 14, Jn Pharma City, Plot No 17, Rno.10, 11 & 19, 20, E Bonangi Vlg,, Vishakhapatnam, Andhra Pradesh, 531021.
U24304AP2020PTC116442
116442
16 November 2020
₹1.00 M
₹1.00 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into Qule Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nityananda Reddy Kambam | Director | 01 Dec 2023 | Current |
| Santhanam Subramanian | Director | 16 Nov 2020 | Current |
| Rama Krishna | Director | 25 Apr 2022 | Current |
| Bala Subramanyam Sami Reddy Palle Reddy | Additional Director | 14 Nov 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Nov 2023 | Past |
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 27 Dec 2023 | Past |
| Pramod Abcsdd | Director | 17 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 26 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Qule Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 10407.07% decrease in profit. The company's net worth Soared by an impressive increase of 106003.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Qule Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,450,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Nov 2024 | State Bank Of India | ₹210.00 Cr | Open |
| 16 May 2023 | Others | ₹335.00 Cr | Open |
Explore comprehensive loan charge details -
Qule Pharma has a workforce of 22 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Qule Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qule Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Bala Subramanyam Sami Reddy Palle Reddy was appointed as a Additional Director was appointed as a Additional Director on 14 Nov 2025 & has been associated with this company since 16 days . was completed.
Progress on Qule Pharma Private Limited last Annual general meeting of members was held on 01 Sep 2025 as per latest MCA records. was documented.
The activity A charge with Others of Rs. 3,350.00 M registered on 16 May 2023 with Charge ID 100730442 was modified on 19 May 2025. was completed.
Qule Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 2,100.00 M with Charge ID 101020726 was registered on 04 Nov 2024. was documented.
Progress on Nityananda Reddy Kambam was appointed as a Director was appointed as a Director on 01 Dec 2023 & has been associated with this company since 2 years . was documented.
The CIN of Qule Pharma Private Limited is U24304AP2020PTC116442.
Qule Pharma Private Limited is headquartered at Unit 14, Jn Pharma City, Plot No 17, Rno.10, 11 & 19, 20, E Bonangi Vlg,, Vishakhapatnam, Andhra Pradesh, 531021.
Qule Pharma Private Limited was incorporated on 16 November 2020.
The current directors of Qule Pharma Private Limited are
The primary industry of Qule Pharma Private Limited is Manufacturing.
Qule Pharma Private Limited is unlisted.
The authorized capital of Qule Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX